Monopar Therapeutics (MNPR) Enterprise Value Growth (3y) (2019 - 2025)
Monopar Therapeutics (MNPR) Enterprise Value Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Monopar Therapeutics | 800.03 Mn | 738.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -96.21% |
| Sep 30, 2025 | -109.31% |
| Jun 30, 2025 | -33.87% |
| Mar 31, 2025 | -30.62% |
| Dec 31, 2024 | -31.79% |
| Sep 30, 2024 | 35.06% |
| Jun 30, 2024 | 36.84% |
| Mar 31, 2024 | 32.80% |
| Dec 31, 2023 | 24.08% |
| Sep 30, 2023 | 32.56% |
| Jun 30, 2023 | 16.84% |
| Mar 31, 2023 | 6.11% |
| Dec 31, 2022 | 14.75% |
| Sep 30, 2022 | -45.78% |
| Jun 30, 2022 | -47.51% |
| Mar 31, 2022 | -44.70% |
| Dec 31, 2021 | -42.66% |
| Sep 30, 2021 | -42.37% |
| Jun 30, 2021 | -43.51% |
| Mar 31, 2021 | -42.06% |